Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Log in
Sign up
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
The latest from Redeye about Scandinavian Life Science and Technology companies
Impact Coatings
Heading for a Strong Finish to 2020
Addnode Group
Q3’20 review: Minor revisions to 2021 despite excellent Q3
CellaVision
Q3’20: Gearing up for 2021
Xvivo Perfusion
Q3’20: Underlying Business still Strong
ProAct IT Group
Q3’20 review: EBITA 2021 raised by 12% due to lowered SG&A
CellaVision
Q3’20: First comments
Westpay
Q3’20: Impressive on All Levels
Carasent
Ecosystem Showing Strength
Clinical Laserthermia Systems
Further advancement with laser
Doro
Q3’20: A First Comment
Addnode Group
Q3’20: All Divisions crushed our EBITA forecasts as margins outperform
Mycronic
Stark pricing power
Fortnox
Q3’20 review: 2021 EBIT forecast raised by 13% due to lowered OPEX estimates
Ascelia Pharma
Stärkt tro på caset
Alligator Bioscience
Q3’20: Klinisk portfölj fallskydd när ATOR-1015 svajar
Sdiptech
Q3’20 review: 2021 EBITA* forecast raised by 6% as cost control pays off